Lenvatinib is a prescription medication used to treat certain types of thyroid cancer. It belongs to a group of drugs called tyrosine kinase inhibitors. It works by stopping the growth of cancer cells. Lenvatinib is usually used when other treatments have not worked. Common side effects include fatigue, nausea, and diarrhea.
Lenvatinib is a prescription medication used to treat various types of cancers. Here's a breakdown of its key features:
Function: Lenvatinib belongs to a class of drugs called multi-tyrosine kinase inhibitors (TKIs). TKIs work by blocking the action of specific enzymes (tyrosine kinases) involved in the growth and spread of cancer cells. By inhibiting these enzymes, Lenvatinib disrupts the signaling pathways essential for tumor cell proliferation and survival.
Applications: Lenvatinib is approved for the treatment of several types of cancers, including:
- Differentiated thyroid carcinoma: This is a type of thyroid cancer that has spread to other parts of the body (locally recurrent or metastatic). Lenvatinib is used in patients who are radioactive iodine-resistant, meaning their cancer did not respond well to treatment with radioactive iodine.
- Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer. Lenvatinib is used in combination with another medication called everolimus to treat advanced HCC.
- Renal cell carcinoma (RCC): This is a type of kidney cancer. Lenvatinib is used after other medications, such as sunitinib or pazopanib, have failed to control the cancer's growth (second-line treatment).
Benefits:
- Improved survival rates: Lenvatinib has shown positive results in clinical trials, demonstrating improved progression-free survival (time without tumor growth) and overall survival rates in patients with certain cancers.
- Targeted therapy: Lenvatinib targets specific pathways involved in cancer cell growth, potentially offering a more precise approach to cancer treatment compared to traditional chemotherapy.
Important Considerations:
- Not a cure: Lenvatinib helps control cancer growth and progression, but it doesn't cure cancer.
- Potential side effects: Lenvatinib can cause various side effects, including high blood pressure, fatigue, diarrhea, rash, mouth sores, and weight loss. Regular monitoring by a doctor is crucial to manage side effects.
- Not for everyone: Lenvatinib may not be suitable for all patients due to underlying health conditions or potential interactions with other medications.
- Pregnancy risks: Lenvatinib can cause severe birth defects and should not be used during pregnancy or by women planning to become pregnant.